Reduced skeletal muscle independently predicts 1-year aggravated joint destruction in patients with rheumatoid arthritis.

When comparing clinical indicators during 1-year follow up among the six subtypes, subtype 1 showed a trend of the best controlled disease indicators, with subtype 3 showing a trend of the worst control (remission rate at 12 month: 73.2%, 59.5%, 43.8%, 50.0%, 62.7%, and 45.0% in subtype 1–6 respectively, p = 0.013 for comparison in six groups, but all p > 0.0033 with Bonferroni correction for multiple comparisons, data not shown), although there was no significant difference among the six subtypes.

also in 53,322 other papers